Bob Wynalek

Chief Operating & Commercialization Officer, Director at DiscGenics

Mr. Wynalek is a skilled medical device and biologics executive with over 30 years of experience in the orthopedic, spinal and neurosurgical markets. Most recently, Mr. Wynalek was the President of domestic business for Osteotech, Inc. where he oversaw development, regulatory clearance and commercialization of numerous biologic devices for bone healing. Osteotech, Inc. was acquired by Medtronic, Inc. in 2010. Mr. Wynalek currently serves as a committee member of the Alliance for Regenerative Medicine and BioUtah.

Links

Previous companies

Smith+Nephew logo
Medtronic logo

Org chart

Peers

Timeline

  • Chief Operating & Commercialization Officer, Director

    Current role

View in org chart